| 注册
首页|期刊导航|基础医学与临床|基于质谱的尿液蛋白质组的临床应用

基于质谱的尿液蛋白质组的临床应用

魏静 孙伟

基础医学与临床2025,Vol.45Issue(8):982-991,10.
基础医学与临床2025,Vol.45Issue(8):982-991,10.DOI:10.16352/j.issn.1001-6325.2025.08.0982

基于质谱的尿液蛋白质组的临床应用

Clinical applications of urine proteome based on mass spectrometry

魏静 1孙伟2

作者信息

  • 1. 国家儿童医学中心首都医科大学附属北京儿童医院临床研究中心,北京 100045
  • 2. 中国医学科学院基础医学研究所北京协和医学院基础学院中心实验室,北京 100005
  • 折叠

摘要

Abstract

Urine is stable,non-invasive obtaining and has simple composition.As urine is not regulated by homeo-static mechanisms,it is easier to detect early changes of disease comparing with blood,making urine as an ideal bi-omarker source.In recent years,with the improvement of mass spectrometry technology and detection throughput,research in the field of clinical urine proteomics has made significant progress.Urine can not only reflect the func-tional changes of the disease at the tissue level,but also provide a new path for monitoring the efficacy of individu-alized medication.This review systematically summarizes the research progress of urine proteomics in the diagnosis of non-urinary system diseases in the past decade(2015-2024).This review also discusses the application of urine proteomics in disease monitoring,prognosis evaluation,drug efficacy assesment,and traditional Chinese med-icine.Finally,future development prospects of urine proteomics are discussed.

关键词

尿蛋白组学/生物标志物/早期诊断/临床应用

Key words

urine proteomics/biomarkers/early diagnosis/clinical application

分类

医药卫生

引用本文复制引用

魏静,孙伟..基于质谱的尿液蛋白质组的临床应用[J].基础医学与临床,2025,45(8):982-991,10.

基金项目

北京市自然科学基金-大兴创新联合基金重点研究专题项目(L246002) (L246002)

基础医学与临床

1001-6325

访问量0
|
下载量0
段落导航相关论文